carbamazepine has been researched along with cholecalciferol in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Christiansen, C; Hummer, L; Rødbro, P; Tjellesen, L | 1 |
Delling, G; Lücking, T | 1 |
Aarskog, D; Aksnes, L; Markestad, T; Strandjord, RE; Ulstein, M | 1 |
Christiansen, C; Gotfredsen, A; Tjellesen, L | 1 |
Tjellesen, L | 1 |
Borowicz, KK; Czuczwar, SJ; Furmanek-Karwowska, K; Luszczki, JJ; Morawska, M | 1 |
Cetinkaya, Y; Kurtulmuş, YS; Tireli, H; Tutkavul, K | 1 |
Assenza, F; Assenza, G; Benvenga, A; Campana, C; Cosimo Quattrocchi, C; Di Lazzaro, V; Giambattistelli, F; Pellegrino, G; Tombini, M; Vernieri, F | 1 |
2 review(s) available for carbamazepine and cholecalciferol
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Metabolism and action of vitamin D in epileptic patients on anticonvulsive treatment and healthy adults.
Topics: Anticonvulsants; Calcium; Carbamazepine; Cholecalciferol; Epilepsy; Ergocalciferols; Female; Humans; Reference Values; Vitamin D | 1994 |
8 other study(ies) available for carbamazepine and cholecalciferol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Different metabolism of vitamin D2 and vitamin D3 in epileptic patients on carbamazepine.
Topics: Adult; Aged; Carbamazepine; Cholecalciferol; Epilepsy; Ergocalciferols; Female; Humans; Male; Middle Aged | 1985 |
[Severe rachitic osteopathy during long-term anticonvulsant treatment].
Topics: Administration, Oral; Alkaline Phosphatase; Anticonvulsants; Biopsy; Calcium; Carbamazepine; Child; Cholecalciferol; Epilepsy, Tonic-Clonic; Humans; Ilium; Iron; Long-Term Care; Male; Osteomalacia; Phenobarbital; Phenytoin; Phosphorus; Primidone; Rickets | 1973 |
Anticonvulsant drug therapy in human pregnancy: effects on serum concentrations of vitamin D metabolites in maternal and cord blood.
Topics: 24,25-Dihydroxyvitamin D 3; Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Calcifediol; Calcitriol; Calcium; Carbamazepine; Cholecalciferol; Dihydroxycholecalciferols; Epilepsy; Female; Fetal Blood; Homeostasis; Humans; Phenytoin; Phosphates; Pregnancy; Pregnancy Complications; Vitamin D | 1984 |
Effect of vitamin D2 and D3 on bone-mineral content in carbamazepine-treated epileptic patients.
Topics: Adult; Aged; Bone and Bones; Carbamazepine; Cholecalciferol; Epilepsy; Ergocalciferols; Female; Humans; Male; Middle Aged; Minerals; Osteomalacia; Vitamin D | 1983 |
Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock.
Topics: Animals; Anticonvulsants; Avoidance Learning; Carbamazepine; Cholecalciferol; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Electroshock; Injections, Intraperitoneal; Male; Mental Recall; Mice; Motor Activity; Phenobarbital; Phenytoin; Seizures; Valproic Acid; Vitamins | 2007 |
The effect of oxcarbazepine on bone metabolism.
Topics: Absorptiometry, Photon; Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcium; Carbamazepine; Cholecalciferol; Female; Humans; Male; Middle Aged; Oxcarbazepine; Phosphates | 2009 |
Osteomalacic myopathy: an uncommon side effect of antiepileptic drugs.
Topics: Anticonvulsants; Bone Density Conservation Agents; Carbamazepine; Cholecalciferol; Epilepsy; Humans; Male; Middle Aged; Muscular Diseases; Osteomalacia; Phenobarbital; Treatment Outcome | 2013 |